Stock Upgrades: Melanoma Making Money for MELA Sciences

Shares in MELA Sciences Inc (Nasdaq: MELA), the medical device company that developed MelaFind, gained 17.2% on volume of 1.67 million in the last trading session before closing at $2.93 after analysts at Cowen initiated coverage on the penny stock. Cowen set an “outperform” rating on MELA stock which is currently trading at -26.83% below and -31.70% below ...

Continue Reading →
0